WDR76 and liver cancer: In vivo and in vitro studies demonstrated that cytoplasmic WDR76 directly mediated RAS polyubiquitination degradation through binding to HRAS, resulting in inhibition of proliferation, transformation, and the invasive ability of liver cancer cells.